{"result": "(\"entity\"<|>HEPATOPATÍA<|>EVENT<|>Hepatopathy refers to liver diseases that can affect the body's metabolism and require dietary management.)\n##\n(\"entity\"<|>NUTRICIÓN ENTERAL<|>EVENT<|>Enteral nutrition is indicated when oral intake is insufficient, often involving the placement of feeding tubes.)\n##\n(\"entity\"<|>NUTRICIÓN PARENTERAL<|>EVENT<|>Parenteral nutrition is used when enteral nutrition is contraindicated, providing nutrients directly into the bloodstream.)\n##\n(\"entity\"<|>SUPLEMENTOS ORALES<|>EVENT<|>Oral supplements are recommended for patients whose diet does not meet their caloric and protein requirements.)\n##\n(\"entity\"<|>VITAMINAS<|>EVENT<|>Vitamins are essential micronutrients that may be deficient in patients with liver diseases.)\n##\n(\"entity\"<|>SONDA NASOGÁSTRICA<|>EVENT<|>A nasogastric tube is used for feeding patients who cannot eat orally, with specific considerations for placement.)\n##\n(\"entity\"<|>VARICES ESOFÁGICAS<|>EVENT<|>Esophageal varices are swollen veins in the esophagus that can complicate feeding tube placement.)\n##\n(\"entity\"<|>PLAQUETOPENIA<|>EVENT<|>Thrombocytopenia refers to a low platelet count, which can affect medical procedures like feeding tube placement.)\n##\n(\"entity\"<|>INR<|>EVENT<|>International Normalized Ratio (INR) is a measure of blood coagulation that is important before certain medical procedures.)\n##\n(\"relationship\"<|>HEPATOPATÍA<|>NUTRICIÓN ENTERAL<|>Hepatopathy often necessitates enteral nutrition when oral intake is insufficient<|>7)\n##\n(\"relationship\"<|>HEPATOPATÍA<|>SUPLEMENTOS ORALES<|>Patients with hepatopathy may require oral supplements to meet their nutritional needs<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN ENTERAL<|>SONDA NASOGÁSTRICA<|>Enteral nutrition typically involves the use of a nasogastric tube for feeding<|>8)\n##\n(\"relationship\"<|>SONDA NASOGÁSTRICA<|>VARICES ESOFÁGICAS<|>The presence of esophageal varices does not contraindicate the placement of a nasogastric tube<|>5)\n##\n(\"relationship\"<|>PLAQUETOPENIA<|>SONDA NASOGÁSTRICA<|>Thrombocytopenia may require treatment before the placement of a nasogastric tube<|>6)\n##\n(\"relationship\"<|>INR<|>SONDA NASOGÁSTRICA<|>An elevated INR may necessitate treatment before placing a nasogastric tube<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>HEPATOPATÍA<|>Parenteral nutrition is reserved for patients with hepatopathy when enteral nutrition is contraindicated<|>7)\n##\n(\"relationship\"<|>VITAMINAS<|>HEPATOPATÍA<|>Deficiencies in vitamins are common in patients with hepatopathy<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: , no precisando restricciones dietéticas. Si toleran más de 70 g de proteínas al día, sin deterioro cognitivo, no son necesarias más restricciones dietéticas. Tan sólo en pacientes con ascitis refractaria al tratamiento diurético se recomienda una restricción de sal y líquidos.\n\nSe recomienda realizar 6-7 tomas al día (para evitar náuseas y sensación precoz de saciedad) y la toma de un suplemento nocturno de unos 50g de hidratos de carbono. La composición de nutrientes de la dieta es similar a la de otras patologías:\n\n- Hidratos de carbono: entre el 50-60% de las KcaL (entre 35-40KcaL/Kg de peso/dia).\n\n- Grasas: entre el 10-20% de las KcaL.\n\n- Proteínas: entre el 20-30% de las KcaL (entre 1.2-1.5gr de proteínas/kg/dia). Solo se debe realizar una restricción proteica en pacientes con hepatopatía y enfermedad renal crónica (aplicando las recomendaciones de la enfermedad renal crónica) o en situación de encefalopatía hepática resistente al tratamiento habitual (restricción transitoria en la encefalopatía de grado leve y hasta su corrección en los casos graves).\n\n142\n---\n- Micronutrientes (vitaminas liposolubles, hidrosolubles y minerales): sus déficits se detectan en el 60% de los pacientes con hepatopatías y son más frecuentes en la etiología enólica.\n\n## 4.3. SUPLEMENTOS ORALES\n\nEstán indicados en aquellos pacientes en los que la dieta oral no permita cubrir sus requerimientos calórico-proteicos. Se recomienda tomarlos entre las comidas.\n\n## 4.4. NUTRICIÓN ENTERAL\n\nEstá indicada cuando la ingesta oral es insuficiente a pesar de la administración de suplementos orales.\n\nSe considera de elección la colocación de sondas de alimentación vía nasogástrica o nasoyeyunal (Grado A de evidencia en las guías ESPEN). No se recomienda la colocación de gastrostomías endoscópicas percutáneas (PEG) por el alto riesgo de complicaciones asociadas a la presencia de alteraciones de la coagulación, varices esofágicas y/o gástricas (en el 30-50% de los pacientes) y, en caso de ascitis, puede provocar una salida de líquido ascítico a través del orificio de colocación de la PEG.\nConsideraciones a tener en cuenta previo a la colocación de la sonda nasogástrica:\n\n- La presencia de varices esofágicas y/o gástricas no contraindica su colocación.\n\n- En caso de plaquetopenia (<50.000 plaquetas) y/o alteraciones del INR (>2.0) se recomienda tratar con plasma fresco, vitamina K o plaquetas previamente a la colocación de la sonda.\n\n- En caso de encefalopatía hepática, será necesario instaurar las medidas adecuadas para que el paciente no se arranque la sonda.\n\nEn cuanto al tipo de fórmula a emplear, en general se recomiendan fórmulas poliméricas, normoproteicas y con un contenido moderado en sodio (40-60 mmol/día). Se pueden emplear otro tipo de fórmulas, como:\n\n- Hiperproteicas: se reservan para situaciones con un aumento de los requerimientos o cuando sea preciso realizar una restricción hídrica (en ese caso, se emplearán fórmulas con una densidad calórica entre 1,3 y 1,4 kcal/ml).\n\n- Ricas en aminoácidos de cadena ramificada (AACR): reservadas para situaciones de encefalopatía refractaria a tratamiento habitual, aportando entre 0,5-1,2 g/kg/día de AACR.\n---\n• Específicas para diabéticos: en caso de mal control de la glucemia.\n\nLa pauta de administración de la nutrición enteral puede ser nocturna (para permitir ingesta oral durante el día) o diurna y el ritmo de administración, continuo o intermitente (recomendándose una perfusión intermitente tan pronto lo permita la tolerancia por ser más fisiológica).\n\n## 4.5. NUTRICIÓN PARENTERAL\n\nSe reserva para aquellos pacientes en los cuales la nutrición enteral esté contraindicada. La ratio de energía suministrada por hidratos de carbono y lípidos debe ser de 65-50/35-50% de calorías no proteicas. El aporte proteico debe ser suplementado por soluciones con AA convencionales, reservándose las soluciones ricas en AACR para situaciones especiales.\n\n## 4.6. CORRECCIÓN DE LOS DÉFICITS DE MICRONUTRIENTES\n\nLas dosis a aportar en caso de déficits de vitaminas lipos\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}